Chatiya Athichathanabadi

Effectiveness and metabolic complications after 96 weeks of a generic fixed-dose combination of stavudine, lamivudine, and nevirapine among antiretroviral-naive advanced HIV-infected patients in Thailand: A prospective study.

W. Prasithsirikul, S. Tansuphaswadikul, W. Manosuthi, 2008, Current therapeutic research, clinical and experimental.

Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole

W. Manosuthi, S. Sungkanuparph, Thanongsri Phoorisri, 2007, BMC infectious diseases.

Risk factors for mortality in symptomatic hyperlactatemia among HIV-infected patients receiving antiretroviral therapy in a resource-limited setting.

W. Prasithsirikul, W. Manosuthi, S. Sungkanuparph, 2008, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir.

K. Ruxrungtham, W. Prasithsirikul, W. Manosuthi, 2008, Journal of acquired immune deficiency syndromes.